首頁 > 市場調查報告書 > 製藥

藥物開發開發業務受託機關

市場調查報告書

商品編碼

1550571

醫療保健 CMO 市場：按服務類型和地區分類

Healthcare CMO Market, By Service Type (Pharmaceutical Contract Manufacturing Services (Active Pharmaceutical Ingredients Manufacturing, Final Dosage Form Manufacturing Packaging) and Medical Device Contract Manufacturing Services ), By Geography

出版日期: 2024年07月31日 | 出版商:

Coherent Market Insights | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球醫療保健 CMO 市場預計 2024 年為 1,711 億美元，預計到 2031 年將達到 4,471.1 億美元，2024 年至 2031 年複合年成長率為 14.7%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	1711億美元
實際資料	2019-2023	預測期	2024年至2031年
預測 2024-2031 年複合年成長率：	14.70%	2031年價值預測	4471.1億美元

圖：2024 年按地區分類的醫療保健 CMO市場佔有率(%)

全球醫療保健 CMO 市場的成長是由全球對高品質藥品不斷成長的需求所推動的。製藥和生物技術公司擴大將製造業務外包給受託製造廠商，以專注於其核心競爭力，例如研發、行銷和銷售。 CMO 提供端到端製造服務，從藥物開發到臨床試驗供應、商業製造、包裝和監管支援。這使得生物製藥製造商能夠降低製造成本並有效地遵守嚴格的監管標準。

市場動態：

全球醫療保健 CMO 市場的成長是由學名藥和生物學名藥市場的擴張、對具有成本效益的藥物製造外包解決方案的需求不斷成長以及藥物開發的研發投資增加等因素推動的。然而，生物製藥開發的複雜性、技術純熟勞工的缺乏以及對生產設施的嚴格監管可能會阻礙市場成長。進入該市場的公司有機會開拓亞太和拉丁美洲的新興市場，這些市場可以獲得低成本的製造地和熟練勞動力。領先的市場參與企業正在積極投資於產能擴張、先進技術和監管能力，以加強其服務組合和全球企業發展。

本研究的主要特點

本報告對全球醫療保健 CMO 市場進行了詳細分析，並提供了以 2023 年為基準年的預測期（2024-2031 年）的市場規模（十億美元）和年複合成長率（CAGR%）。它。

它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

它包括基於公司亮點、產品系列、主要亮點、財務績效和策略等參數的全球醫療保健 CMO 市場主要企業的概況。

本研究涵蓋的主要企業包括 Catalent Inc.、Recipharm AB、Aurobindo Pharma Limited、Jubilant Life Sciences Ltd.、Boehringer Ingelheim GmbH、Lonza Group、Patheon Inc. 等。

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

全球醫療保健 CMO 市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球醫療保健 CMO 市場的各種策略矩陣，將有助於相關人員做出決策。

公司簡介
- Lonza Group
- Catalent, Inc.
- Thermo Fisher Scientific（Patheon）
- Recipharm AB
- Siegfried Holding AG
- Aenova Group
- Almac Group
- Piramal Pharma Solutions
- Evonik Industries AG
- Famar Health Care Services
- Boehringer Ingelheim
- Consort Medical plc
- Pfizer CentreOne
- Baxter BioPharma Solutions
- Jubilant HollisterStier
- Vetter Pharma International GmbH
- Ajinomoto Bio-Pharma Services
- Fareva Group

第8章分析師建議

命運之輪
分析師觀點
一致的機會圖

第9章參考文獻及調查方法

參考
調查方法

簡介目錄

Product Code: CMI4622

Global healthcare CMO market is estimated to be valued at USD 171.10 Bn in 2024 and is expected to reach USD 447.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.7% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 171.10 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	14.70%	2031 Value Projection:	US$ 447.11 Bn

Figure. Healthcare CMO Market Share (%), By Region 2024

Global healthcare CMO market growth is driven by rising demand for high-quality pharmaceutical products across the world. Various pharmaceutical and biotechnology companies are increasingly outsourcing their manufacturing operations to contract manufacturing organizations, in order to focus on their core competencies of research and development, marketing and sales. The CMOs provide end-to-end manufacturing services right from drug development, clinical trial supplies, commercial manufacturing, packaging and regulatory support. This enables the biopharmaceutical players to reduce manufacturing costs and comply with stringent regulatory norms in a time-efficient manner.

Market Dynamics:

Global healthcare CMO market growth is driven by factors such as rising generic and biosimilar drugs market, growing demand for cost-effective pharmaceutical manufacturing outsourcing solutions, and increasing R&D investment in drug development. However, complexity in developing biological drugs, lack of skilled workforce and stringent regulations for manufacturing facilities can hamper the market growth. The companies in this market have opportunity to tap the emerging markets in Asia Pacific and Latin America, owing to availability of low-cost manufacturing base and skilled labor. Key market players are investing heavily in capacity expansion, advanced technologies and regulatory capabilities to strengthen their service portfolio and global footprint.

Key Features of the Study:

This report provides in-depth analysis of the global healthcare CMO market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global healthcare CMO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Catalent Inc., Recipharm AB, Aurobindo Pharma Limited, Jubilant Life Sciences Ltd., Boehringer Ingelheim GmbH, Lonza Group, and Patheon Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global healthcare CMO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare CMO market

Detailed Segmentation-

By Service Type
- Pharmaceutical Contract Manufacturing Services
- Active Pharmaceutical Ingredients (API) Manufacturing
- Final Dosage Form (FDF) Manufacturing Packaging
- Medical Device Contract Manufacturing Services
- Outsourcing Design
- Device Manufacturing
- Material Process Services
- Electronic Manufacturing Services
- Finished Products
- Final Goods Assembly
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Lonza Group
- Catalent, Inc.
- Thermo Fisher Scientific (Patheon)
- Recipharm AB
- Siegfried Holding AG
- Aenova Group
- Almac Group
- Piramal Pharma Solutions
- Evonik Industries AG
- Famar Health Care Services
- Boehringer Ingelheim
- Consort Medical plc
- Pfizer CentreOne
- Baxter BioPharma Solutions
- Jubilant HollisterStier
- Vetter Pharma International GmbH
- Ajinomoto Bio-Pharma Services
- Fareva Group

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Healthcare CMO Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Healthcare CMO Market, By Service Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Pharmaceutical Contract Manufacturing Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Active Pharmaceutical Ingredients (API) Manufacturing
Final Dosage Form (FDF) Manufacturing Packaging
Medical Device Contract Manufacturing Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Outsourcing Design
Device Manufacturing
Material Process Services
Electronic Manufacturing Services
Finished Products
Final Goods Assembly

6. Global Healthcare CMO Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Company Profiles
- Lonza Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Catalent, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Thermo Fisher Scientific (Patheon)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Recipharm AB
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Siegfried Holding AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Aenova Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Almac Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Piramal Pharma Solutions
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Evonik Industries AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Famar Health Care Services
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Consort Medical plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer CentreOne
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Baxter BioPharma Solutions
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Jubilant HollisterStier
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Vetter Pharma International GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ajinomoto Bio-Pharma Services
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Fareva Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies